HYPEN Side Effects

6750291-7 | Melaena
on May 19, 2010 Female patient from JAPAN , 94 years of age, was diagnosed with periarthritis, osteoporosis (What is osteoporosis?) and was treated with Hypen (View Usage). Patient experienced the following unwanted or unexpected effects: melaena. Hypen dosage: 400 Mg, Unk. During the same period patient was treated with NORVASC (2.5 Mg/day) (View Norvasc Review and Norvasc Label ), ONE ALPHA (0.5 Ug, Daily) (View One-alpha Review and One-alpha Label ), TAKEPRON (15 Mg, Daily) (View Takepron Review and Takepron Label ), ESTRIEL (0.5 Mg, Daily) (View Estriel Review and Estriel Label ), DIOVANE (40 Mg, Daily) (View Diovane Review and Diovane Label ), DIART (30 Mg/day) (View Diart Review and Diart Label ), KELNAC (160 Mg/day) (View Kelnac Review and Kelnac Label ). Patient was hospitalized.

6070090-1 | Platelet Count Decreased
Patient was taking Hypen (View Usage). Patient had the following side effects: platelet count decreased on Feb 05, 2009 from JAPAN Additional patient health information: Female patient , 84 years of age, was diagnosed with osteoarthritis (What is osteoarthritis?) and. Hypen dosage: Not Specified. During the same period patient was treated with CAMOSTAT MESILATE (Not Specified) (View Camostat Mesilate Review and Camostat Mesilate Label ).

6041708-4 | Interstitial Lung Disease
Adverse event was reported on Jan 13, 2009 by a Male patient taking Hypen (View Usage) (Dosage: ) . Location: JAPAN , 72 years of age, After Hypen was administered, patient had the following side effects: interstitial lung disease.

6016340-9 | Analgesic Asthma Syndrome
on Dec 10, 2008 Male patient from JAPAN , 33 years of age, was treated with Hypen (View Usage). Patient experienced the following unwanted or unexpected effects: analgesic asthma syndrome. Hypen dosage: . During the same period patient was treated with TIARAMIDE HYDROCHLORIDE (View Tiaramide Hydrochloride Review and Tiaramide Hydrochloride Label ), MELOXICAM (View Meloxicam Review and Meloxicam Label ).


5938619-9 | Liver Disorder, Rash Macular
on Oct 23, 2008 Female patient from JAPAN , 53 years of age, was treated with Hypen (View Usage). Patient had the following side effects: liver disorder, rash macular. Hypen dosage: .

5835681-9 | Platelet Count Decreased
Patient was taking Hypen (View Usage). After Hypen was administered, patient had the following side effects: platelet count decreased on Jul 29, 2008 from JAPAN Additional patient health information: Female patient , 84 years of age, was diagnosed with osteoarthritis (What is osteoarthritis?) and. Hypen dosage: Not Specified. During the same period patient was treated with CAMOSTAT MESILATE (Not Specified) (View Camostat Mesilate Review and Camostat Mesilate Label ).

5806814-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Gamma-glutamyltransferase Increased, Liver Disorder
Adverse event was reported on Jul 02, 2008 by a Female patient taking Hypen (View Usage) (Dosage: ) . Location: JAPAN , 71 years of age, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, liver disorder. During the same period patient was treated with MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), TERBINAFINE HCL (View Terbinafine Hcl Review and Terbinafine Hcl Label ), GATIFLOXACIN (View Gatifloxacin Review and Gatifloxacin Label ).

5669753-9 | Ulcer Haemorrhage
on Mar 10, 2008 Female patient from JAPAN , 77 years of age, was treated with Hypen (View Usage). Patient had the following side effects: ulcer haemorrhage. Hypen dosage: . Patient was hospitalized.

5601081-X | Pneumonia, Sepsis, Stevens-johnson Syndrome
on Jan 10, 2008 Male patient from JAPAN , 80 years of age, was diagnosed with lumbar spinal stenosis and was treated with Hypen (View Usage). After Hypen was administered, patient had the following side effects: pneumonia (What is pneumonia?), sepsis (What is sepsis?), stevens-johnson syndrome. Hypen dosage: . During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), BENIDIPINE (View Benidipine Review and Benidipine Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), REBAMIPIDE (View Rebamipide Review and Rebamipide Label ).

5597089-3 | Faeces Discoloured, Melaena, Small Intestine Ulcer, Vertigo
Patient was taking Hypen (View Usage). Patient experienced the following unwanted or unexpected effects: faeces discoloured, melaena, small intestine ulcer, vertigo on Jan 09, 2008 from JAPAN Additional patient health information: Female patient , 81 years of age, was diagnosed with back pain (What is back pain?) and. Hypen dosage: . Patient was hospitalized.

5583931-9 | Haematemesis, Pneumonia, Sepsis, Stevens-johnson Syndrome
Adverse event was reported on Dec 27, 2007 by a Male patient taking Hypen (View Usage) (Dosage: ) was diagnosed with lumbar spinal stenosis and. Location: JAPAN , 80 years of age, Patient had the following side effects: haematemesis, pneumonia (What is pneumonia?), sepsis (What is sepsis?), stevens-johnson syndrome. During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), BENIDIPINE (View Benidipine Review and Benidipine Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), REBAMIPIDE (View Rebamipide Review and Rebamipide Label ).

5446253-2 | Glomerulonephritis Membranous, Musculoskeletal Stiffness
on Sep 04, 2007 Female patient from JAPAN , 56 years of age, was diagnosed with arthralgia and was treated with Hypen (View Usage). After Hypen was administered, patient had the following side effects: glomerulonephritis membranous, musculoskeletal stiffness. Hypen dosage: . Patient was hospitalized.

5419671-6 | Abdominal Pain Upper, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased
on Aug 13, 2007 Female patient from JAPAN , 64 years of age, was treated with Hypen (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased. Hypen dosage: Daily Dose Not Specified. During the same period patient was treated with ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), ROSUVASTATIN (View Rosuvastatin Review and Rosuvastatin Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), FEXOFENADINE HYDROCHLORIDE (View Fexofenadine Hydrochloride Review and Fexofenadine Hydrochloride Label ). Patient was hospitalized.

5401604-X | Liver Disorder
Patient was taking Hypen (View Usage). Patient had the following side effects: liver disorder on Jul 20, 2007 from JAPAN Additional patient health information: Male patient , 86 years of age, . Hypen dosage: . Patient was hospitalized.

5392099-3 | Colitis Ulcerative
Adverse event was reported on Jul 13, 2007 by a Male patient taking Hypen (View Usage) (Dosage: ) was diagnosed with back pain (What is back pain?) and. Location: JAPAN , 66 years of age, After Hypen was administered, patient had the following side effects: colitis ulcerative. During the same period patient was treated with REBAMIPIDE (View Rebamipide Review and Rebamipide Label ), TICLOPIDINE HYDROCHLORIDE (View Ticlopidine Hydrochloride Review and Ticlopidine Hydrochloride Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), IMIDAPRIL HYDROCHLORIDE (View Imidapril Hydrochloride Review and Imidapril Hydrochloride Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ). Patient was hospitalized.

5382954-2 | Colitis Ulcerative
on Jul 02, 2007 Male patient from JAPAN , 66 years of age, was diagnosed with back pain (What is back pain?) and was treated with Hypen (View Usage). Patient experienced the following unwanted or unexpected effects: colitis ulcerative. Hypen dosage: . During the same period patient was treated with REBAMIPIDE (View Rebamipide Review and Rebamipide Label ), TICLOPIDINE HYDROCHLORIDE (View Ticlopidine Hydrochloride Review and Ticlopidine Hydrochloride Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), IMIDAPRIL HYDROCHLORIDE (View Imidapril Hydrochloride Review and Imidapril Hydrochloride Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5373700-7 | Interstitial Lung Disease
on Jun 18, 2007 Female patient from JAPAN , 58 years of age, was diagnosed with arthralgia and was treated with Hypen (View Usage). Patient had the following side effects: interstitial lung disease. Hypen dosage: 200 Mg, One Dose. During the same period patient was treated with IRSOGLADINE MALEATE (View Irsogladine Maleate Review and Irsogladine Maleate Label ).

5318989-5 | Blood Pressure Systolic Decreased, Diarrhoea, Shock, Vomiting
Patient was taking Hypen (View Usage). After Hypen was administered, patient had the following side effects: blood pressure systolic decreased, diarrhoea, shock, vomiting on Apr 26, 2007 from JAPAN Additional patient health information: Female patient , 72 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Hypen dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), BUCILLAMINE (View Bucillamine Review and Bucillamine Label ). Patient was hospitalized.

5291881-0 | Pancytopenia, Pseudomembranous Colitis, Sepsis
Adverse event was reported on Mar 29, 2007 by a Female patient taking Hypen (View Usage) (Dosage: ) . Location: JAPAN , 89 years of age, Patient experienced the following unwanted or unexpected effects: pancytopenia, pseudomembranous colitis, sepsis (What is sepsis?).

5256725-1 | Haematemesis
on Feb 23, 2007 Female patient from JAPAN , 79 years of age, was diagnosed with back pain (What is back pain?) and was treated with Hypen (View Usage). Patient had the following side effects: haematemesis. Hypen dosage: 400 Mg. During the same period patient was treated with GASLON (4 Mg) (View Gaslon Review and Gaslon Label ).

4638967-9 | Choroidal Detachment, Retinal Detachment, Visual Acuity Reduced
on Sep 30, 2004 Female patient from , 51 years of age, weighting 101.4 lb, was diagnosed with systemic lupus erythematosus and was treated with Hypen (View Usage). After Hypen was administered, patient had the following side effects: choroidal detachment, retinal detachment, visual acuity reduced. Hypen dosage: 400 Mg/d. During the same period patient was treated with NEORAL (50 Mg/d) (View Neoral Review and Neoral Label ), PREDNISOLONE (30 Mg/d) (View Prednisolone Review and Prednisolone Label ), GASTER (40 Mg/d) (View Gaster Review and Gaster Label ), RHEUMATREX (View Rheumatrex Review and Rheumatrex Label ), FOLIAMIN (5 Mg/d) (View Foliamin Review and Foliamin Label ).

4626257-X | Choroidal Detachment, Retinal Detachment, Visual Acuity Reduced
Patient was taking Hypen (View Usage). Patient experienced the following unwanted or unexpected effects: choroidal detachment, retinal detachment, visual acuity reduced on Sep 30, 2004 from Additional patient health information: Female patient , 51 years of age, weighting 101.4 lb, was diagnosed with systemic lupus erythematosus and. Hypen dosage: 400 Mg/d. During the same period patient was treated with NEORAL (50 Mg/d) (View Neoral Review and Neoral Label ), PREDONINE (30 Mg/d) (View Predonine Review and Predonine Label ), GASTER (40 Mg/d) (View Gaster Review and Gaster Label ), RHEUMATREX (View Rheumatrex Review and Rheumatrex Label ), FOLIAMIN (5 Mg/d) (View Foliamin Review and Foliamin Label ).